Search research articles
Contact Us
Filters
Showing results (31-40 of 41) with videos related to
Page
of 5
Sort By:
Plos Pathogens
|
July 28, 2021
Altered microRNA expression in COVID-19 patients enables identification of SARS-CoV-2 infection
Ryan J Farr, Christina L Rootes, Louise C Rowntree, et al.
Plos Pathogens
|
October 27, 2016
Dual microRNA Screens Reveal That the Immune-Responsive miR-181 Promotes Henipavirus Entry and Cell-Cell Fusion
Chwan Hong Foo, Christina L Rootes, Karla Cowley, et al.
Plos Pathogens
|
March 25, 2016
Genome-wide siRNA Screening at Biosafety Level 4 Reveals a Crucial Role for Fibrillarin in Henipavirus Infection
Celine Deffrasnes, Glenn A Marsh, Chwan Hong Foo, et al.
Internal Medicine Journal
|
December 6, 2018
Cluster of invasive Mycobacteria chimaera infections following cardiac surgery demonstrating novel clinical features and risks of aortic valve replacement
Kristen Overton, Vidthyia Mennon, Nomvuyo Mothobi, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America
|
September 10, 2015
Combination of Vancomycin and β-Lactam Therapy for Methicillin-Resistant Staphylococcus aureus Bacteremia: A Pilot Multicenter Randomized Controlled Trial
Joshua S Davis, Archana Sud, Matthew V N O'Sullivan, et al.
Internal Medicine Journal
|
November 22, 2025
Convalescent plasma in hospitalised patients with COVID-19
Zoe McQuilten, Matthew V N O'Sullivan, Damien Purcell, et al.
Open Forum Infectious Diseases
|
July 27, 2023
Longer-term Mortality and Kidney Outcomes of Participants in the Combination Antibiotics for Methicillin-Resistant <i>Staphylococcus aureus</i> (CAMERA2) Trial: A Post Hoc Analysis
Amy Legg, Matthew A Roberts, Jane Davies, et al.
JAMA
|
February 12, 2020
Effect of Vancomycin or Daptomycin With vs Without an Antistaphylococcal β-Lactam on Mortality, Bacteremia, Relapse, or Treatment Failure in Patients With MRSA Bacteremia: A Randomized Clinical Trial
Steven Y C Tong, David C Lye, Dafna Yahav, et al.
NEJM Evidence
|
February 6, 2024
A Randomized Trial of Nafamostat for Covid-19
Susan C Morpeth, Balasubramanian Venkatesh, James A Totterdell, et al.
NEJM Evidence
|
February 6, 2024
Anticoagulation Strategies in Non-Critically Ill Patients with Covid-19
Zoe K McQuilten, Balasubramanian Venkatesh, Vivekanand Jha, et al.
Page
of 5
Search research articles
Search
Showing results (31-40 of 41) with videos related to
Sort By:
Page
of 5
Plos Pathogens
|
July 28, 2021
Altered microRNA expression in COVID-19 patients enables identification of SARS-CoV-2 infection
Ryan J Farr, Christina L Rootes, Louise C Rowntree, et al.
Plos Pathogens
|
October 27, 2016
Dual microRNA Screens Reveal That the Immune-Responsive miR-181 Promotes Henipavirus Entry and Cell-Cell Fusion
Chwan Hong Foo, Christina L Rootes, Karla Cowley, et al.
Plos Pathogens
|
March 25, 2016
Genome-wide siRNA Screening at Biosafety Level 4 Reveals a Crucial Role for Fibrillarin in Henipavirus Infection
Celine Deffrasnes, Glenn A Marsh, Chwan Hong Foo, et al.
Internal Medicine Journal
|
December 6, 2018
Cluster of invasive Mycobacteria chimaera infections following cardiac surgery demonstrating novel clinical features and risks of aortic valve replacement
Kristen Overton, Vidthyia Mennon, Nomvuyo Mothobi, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America
|
September 10, 2015
Combination of Vancomycin and β-Lactam Therapy for Methicillin-Resistant Staphylococcus aureus Bacteremia: A Pilot Multicenter Randomized Controlled Trial
Joshua S Davis, Archana Sud, Matthew V N O'Sullivan, et al.
Internal Medicine Journal
|
November 22, 2025
Convalescent plasma in hospitalised patients with COVID-19
Zoe McQuilten, Matthew V N O'Sullivan, Damien Purcell, et al.
Open Forum Infectious Diseases
|
July 27, 2023
Longer-term Mortality and Kidney Outcomes of Participants in the Combination Antibiotics for Methicillin-Resistant <i>Staphylococcus aureus</i> (CAMERA2) Trial: A Post Hoc Analysis
Amy Legg, Matthew A Roberts, Jane Davies, et al.
JAMA
|
February 12, 2020
Effect of Vancomycin or Daptomycin With vs Without an Antistaphylococcal β-Lactam on Mortality, Bacteremia, Relapse, or Treatment Failure in Patients With MRSA Bacteremia: A Randomized Clinical Trial
Steven Y C Tong, David C Lye, Dafna Yahav, et al.
NEJM Evidence
|
February 6, 2024
A Randomized Trial of Nafamostat for Covid-19
Susan C Morpeth, Balasubramanian Venkatesh, James A Totterdell, et al.
NEJM Evidence
|
February 6, 2024
Anticoagulation Strategies in Non-Critically Ill Patients with Covid-19
Zoe K McQuilten, Balasubramanian Venkatesh, Vivekanand Jha, et al.
Page
of 5